0001127602-23-026027.txt : 20231017
0001127602-23-026027.hdr.sgml : 20231017
20231017185049
ACCESSION NUMBER: 0001127602-23-026027
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231016
FILED AS OF DATE: 20231017
DATE AS OF CHANGE: 20231017
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Farrell Michael J.
CENTRAL INDEX KEY: 0001485164
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15317
FILM NUMBER: 231330598
MAIL ADDRESS:
STREET 1: C/O REMED INC
STREET 2: 9001 SPECTRUM CTR. BLVD.
CITY: SAN DIEGO,
STATE: CA
ZIP: 92123
FORMER NAME:
FORMER CONFORMED NAME: Farrell Michael
DATE OF NAME CHANGE: 20100224
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RESMED INC
CENTRAL INDEX KEY: 0000943819
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 980152841
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 9001 SPECTRUM CENTER BLVD.
CITY: SAN DIEGO
STATE: CA
ZIP: 92123
BUSINESS PHONE: 8587462400
MAIL ADDRESS:
STREET 1: 9001 SPECTRUM CENTER BLVD.
CITY: SAN DIEGO
STATE: CA
ZIP: 92123
4
1
form4.xml
PRIMARY DOCUMENT
X0508
4
2023-10-16
0000943819
RESMED INC
RMD
0001485164
Farrell Michael J.
RESMED INC.
9001 SPECTRUM CENTER BLVD
SAN DIEGO
CA
92123
1
Chief Executive Officer
1
ResMed Common Stock
0
I
Lisette and Michael Farrell Foundation
ResMed Common Stock
4090
I
Lisette and Michael Farrell Family Trust
ResMed Common Stock
2023-10-16
4
M
0
5675
57.76
A
455035
D
ResMed Common Stock
2023-10-16
4
S
0
5675
140.6985
D
449360
D
ResMed Common Stock Options
57.76
2023-10-16
4
M
0
5675
0
D
2017-11-11
2023-11-16
ResMed Common Stock
5675
9140
D
The transaction was conducted under a Rule 10b5-1 plan adopted November 8, 2021.
This transaction was executed in multiple trades at prices ranging from $139.745 to 141.56. The price reported above reflects the weighted average sale price.
Options are exercisable 1/3 each year beginning 1 year from date of grant.
Michael J. Farrell, Chief Executive Officer
2023-10-17